Skip to main content

Month: February 2026

ImageneBio to Participate in Leerink Global Healthcare Conference

SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) — ImageneBio, Inc. (Nasdaq: IMA, “Imagene,” or the “Company”), today announced management will participate in a fireside chat and hold one-on-one meetings at the 2026 Leerink Global Healthcare Conference taking place March 8-11 in Miami, Florida. Fireside Date: Tuesday, March 10Time: 3:00pm ESTWebcast: Linked here and archived for 90 days on events page on the Imagene IR website About ImageneBio, Inc. Imagene is a clinical-stage biotechnology company dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases with differentiated clinical profiles. The Company’s program, IMG-007, is a receptor targeting, nondepleting anti-OX40 monoclonal antibody with multiple differentiating features. Imagene has completed Phase 1b/2a clinical trials of IMG-007...

Continue reading

CPI Aerostructures Receives $4.2M Order from Embraer for Engine Inlet Assemblies

EDGEWOOD, N.Y., Feb. 26, 2026 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero” or the “Company”) (NYSE American: CVU) announced that Embraer S.A. of Brazil (NYSE: EMBJ) has placed several additional orders totaling $4.2 million against a previously announced Life of Program Agreement to manufacture engine inlet assemblies for the Embraer Phenom 300 business jets. These new orders will see deliveries continue through mid-2026 with continued funding anticipated in support of this life-of-program contract. Embraer Executive Aviation’s Phenom 300 continues to lead its class, with 72 units delivered in 2025, the highest in 15 years, reinforcing production upside into 2026. “CPI Aero has been a supplier of Engine Inlets to Embraer since 2012. As of December 2025, we have delivered over 940 shipsets for the Phenom 300 business...

Continue reading

Kratos Completes Critical Design Review for Space Development Agency’s Advanced Fire Control Ground Infrastructure (AFCGI) System

Successfully integrated and validated systems across a complex, multi-partner ground architecture SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in Defense, National Security and Global Markets, has successfully completed the Critical Design Review (CDR) for the Space Development Agency’s Advanced Fire Control Ground Infrastructure (AFCGI) system. Kratos’ completion of the CDR with zero liens allows the program to continue an accelerated schedule and remain aligned with anticipated launch dates. Kratos completed the AFCGI CDR only eight months after the program’s Preliminary Design Review, which itself was finished in just five months from contract award, underscoring the company’s ability to advance complex systems on a rapid timeline. In 2024 Kratos...

Continue reading

Karat Packaging to Report 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Thursday, March 12, 2026

CHINO, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) — Karat Packaging Inc. (“Karat” or the “Company”) (Nasdaq: KRT), a specialty distributor and manufacturer of environmentally friendly, disposable foodservice products and related items, today announced it will release its 2025 fourth quarter and full year financial results after market close on Thursday, March 12, 2026. The Company will host an investor conference call on the same day.Call Date: Thursday, March 12, 2026Time: 2:00 p.m. PT/5:00 p.m. ETPhone: 877-418-4045 (domestic); 412-317-6745 (international)Conference ID: Karat Packaging Inc.Webcast: Accessible at https://irkarat.com/events-presentations/; archive available for approximately one yearAbout Karat Packaging Inc. Karat Packaging Inc. is a specialty distributor and manufacturer of a wide range of disposable...

Continue reading

MicroCloud Hologram Inc. Proposes Quantum AI Simulator Adopting Hybrid CPU-FPGA Method, Achieving Efficient Image Classification Simulation Through Heterogeneous Computing

SHENZHEN, China, Feb. 26, 2026 (GLOBE NEWSWIRE) — MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, proposed a quantum AI simulator that adopts a hybrid CPU-FPGA method. This system performs hardware-level optimization on the specific structure of quantum kernels through a heterogeneous computing architecture, making quantum kernel estimation 500 times faster than traditional CPU simulation implementations under the same computational scale, providing unprecedented acceleration capabilities for the application simulation of quantum artificial intelligence. This technology of HOLO focuses on application-specific quantum kernels (ASQK) designed for image classification tasks, and for the first time implements its core computational process on a Field Programmable Gate Array...

Continue reading

SAGA Metals Announces Expiry of Warrant Acceleration Program and Receipt of C$3,422,888 in Warrant Proceeds since January 1, 2026

VANCOUVER, British Columbia, Feb. 26, 2026 (GLOBE NEWSWIRE) — SAGA Metals Corp. (“SAGA” or the “Company”) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company focused on critical mineral discoveries, is pleased to announce the successful completion and expiry of its Warrant Acceleration Program (the “Acceleration”) of outstanding common share purchase Warrants of the Company issued in connection with a financing that closed in two tranches on May 23 and July 31, 2025 (the “May Financing”) and a financing that closed on October 10, 2025 (the “October Financing”; together with the May Financing, the “Financings”). The Company issued an aggregate of 6,637,667 warrants and 163,146 finder’s warrants (together, the “May Warrants”) in connection with the May Financing. The Company also issued...

Continue reading

10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders

SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow based on the unbiased, genome-wide approach of optical genome...

Continue reading

StoneX Digital Launches Digital Asset Lending Capability

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) — StoneX Group Inc. (“StoneX”; NASDAQ: SNEX) today announced that StoneX Digital, a division of StoneX, has launched a digital asset lending capability, expanding the firm’s existing brokerage and financing services for institutional clients. StoneX Digital connects institutional clients to digital asset markets through spot execution, listed products, such as exchange-traded funds and futures, and financing solutions within a single institutional framework. The introduction of this lending capability extends those services and aims to support clients seeking additional liquidity and capital efficiency while maintaining exposure to digital assets within broader trading and investment strategies. Institutional market participants increasingly require financing tools that align with both digital...

Continue reading

PROCEPT BioRobotics® Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term Growth

Company outlines path to leadership in BPH, including near-term focus on procedure growth through patient-centric solutions and increased organizational discipline Strong revenue outlook, procedure growth, expanding margins, and path to profitability Longer-term growth drivers include market expansion and expanded application into prostate cancerNEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) — PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today hosted its 2026 Investor Day event in New York to detail the Company’s market opportunity, long-term strategy and growth goals, and 2026 – 2027 financial guidance. During the event, PROCEPT executive team members outlined the large, underpenetrated opportunity...

Continue reading

Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results

Total Revenue of $276.3 Million, with MACI Revenue Growth of 21% to $239.5 Million Net Income Growth of 59% to $16.5 Million Fourth Quarter Total Revenue and MACI Revenue Growth of 23% Record Fourth Quarter Gross Margin of 79% and Adjusted EBITDA Margin of 40% Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Financial HighlightsTotal net revenue growth of 23% to $92.9 million MACI® net revenue growth of 23% to $84.1 million Burn Care net revenue of $8.8 million Gross margin of 79% Net income increased 17% to $23.2 million Non-GAAP...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.